Inogen Earnings Estimate

INGN Stock  USD 5.86  0.20  3.53%   
The next projected EPS of Inogen is estimated to be -0.225 with future projections ranging from a low of -0.25 to a high of -0.2. Inogen's most recent 12-month trailing earnings per share (EPS TTM) is at -1.0. Please be aware that the consensus of earnings estimates for Inogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
 
Interest Hikes
Inogen is projected to generate -0.225 in earnings per share on the 31st of March 2026. Inogen earnings estimates show analyst consensus about projected Inogen Inc EPS (Earning Per Share). It derives the highest and the lowest estimates based on Inogen's historical volatility. Many public companies, such as Inogen, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Inogen's earnings estimates, investors can diagnose different trends across Inogen's analyst sentiment over time as well as compare current estimates against different timeframes. As of the 10th of February 2026, Gross Profit is likely to drop to about 120.1 M. In addition to that, Pretax Profit Margin is likely to drop to -0.12Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Inogen Earnings Estimation Breakdown

The calculation of Inogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Inogen is estimated to be -0.225 with the future projection ranging from a low of -0.25 to a high of -0.2. Please be aware that this consensus of annual earnings estimates for Inogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
-0.25
Lowest
Expected EPS
-0.225
-0.2
Highest

Inogen Earnings Projection Consensus

Suppose the current estimates of Inogen's value are higher than the current market price of the Inogen stock. In this case, investors may conclude that Inogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Inogen's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2026Current EPS (TTM)
230.82%
0.0
-0.225
-1.0

Inogen Earnings History

Earnings estimate consensus by Inogen Inc analysts from Wall Street is used by the market to judge Inogen's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Inogen's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Inogen Quarterly Gross Profit

46.95 Million

As of the 10th of February 2026, Price Earnings To Growth Ratio is likely to grow to 0.11, though Retained Earnings are likely to grow to (167 M). As of the 10th of February 2026, Common Stock Shares Outstanding is likely to drop to about 22.9 M. In addition to that, Net Loss is likely to grow to about (71.6 M).
Hype
Prediction
LowEstimatedHigh
3.225.848.46
Details
Intrinsic
Valuation
LowRealHigh
5.107.7210.34
Details
3 Analysts
Consensus
LowTargetHigh
11.8313.0014.43
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inogen. Your research has to be compared to or analyzed against Inogen's peers to derive any actionable benefits. When done correctly, Inogen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Inogen Inc. Note that many institutional investors and large investment bankers can move markets due to the volume of Inogen assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Inogen. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Inogen's stock price in the short term.

Inogen Earnings per Share Projection vs Actual

Actual Earning per Share of Inogen refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Inogen Inc predict the company's earnings will be in the future. The higher the earnings per share of Inogen, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Inogen Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Inogen, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Inogen should always be considered in relation to other companies to make a more educated investment decision.

Inogen Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Inogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2025-11-05
2025-09-30-0.21-0.20.01
2025-08-07
2025-06-30-0.27-0.150.1244 
2025-05-05
2025-03-31-0.25-0.110.1456 
2025-02-25
2024-12-31-0.49-0.240.2551 
2024-11-07
2024-09-30-0.49-0.250.2448 
2024-08-06
2024-06-30-0.55-0.240.3156 
2024-05-07
2024-03-31-0.76-0.620.1418 
2024-02-27
2023-12-31-0.62-1.14-0.5283 
2023-11-07
2023-09-30-0.49-0.55-0.0612 
2023-08-07
2023-06-30-0.59-0.420.1728 
2023-05-04
2023-03-31-0.81-0.88-0.07
2023-02-23
2022-12-31-0.57-0.20.3764 
2022-11-02
2022-09-30-0.42-0.420.0
2022-08-04
2022-06-30-0.37-0.150.2259 
2022-05-05
2022-03-31-0.51-0.62-0.1121 
2022-02-24
2021-12-31-0.73-1.01-0.2838 
2021-11-04
2021-09-30-0.260.530.79303 
2021-08-04
2021-06-30-0.110.220.33300 
2021-05-04
2021-03-31-0.27-0.030.2488 
2021-02-24
2020-12-31-0.26-0.230.0311 
2020-11-04
2020-09-30-0.02-0.08-0.06300 
2020-08-04
2020-06-30-0.080.120.2250 
2020-05-05
2020-03-31-0.11-0.070.0436 
2020-02-25
2019-12-310.1-0.06-0.16160 
2019-11-05
2019-09-300.230.310.0834 
2019-08-07
2019-06-300.490.45-0.04
2019-05-07
2019-03-310.30.24-0.0620 
2019-02-26
2018-12-310.250.440.1976 
2018-11-06
2018-09-300.520.730.2140 
2018-08-07
2018-06-300.440.650.2147 
2018-04-30
2018-03-310.290.480.1965 
2018-02-27
2017-12-310.230.310.0834 
2017-11-07
2017-09-300.290.330.0413 
2017-08-03
2017-06-300.280.380.135 
2017-05-09
2017-03-310.140.270.1392 
2017-02-28
2016-12-310.110.250.14127 
2016-11-03
2016-09-300.130.160.0323 
2016-08-04
2016-06-300.20.250.0525 
2016-05-09
2016-03-310.120.11-0.01
2016-03-14
2015-12-310.070.190.12171 
2015-11-10
2015-09-300.130.130.0
2015-08-11
2015-06-300.140.170.0321 
2015-04-27
2015-03-310.030.060.03100 
2015-02-03
2014-12-310.030.060.03100 
2014-11-11
2014-09-300.060.110.0583 
2014-08-12
2014-06-300.070.110.0457 
2014-05-13
2014-03-310.040.050.0125 
2014-03-27
2013-12-310.020.01-0.0150 

About Inogen Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Inogen earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Inogen estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Inogen fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-175.8 M-167 M
Retained Earnings Total Equity-16.7 M-15.8 M
Earnings Yield(0.19)(0.18)
Price Earnings Ratio(6.95)(6.60)
Price Earnings To Growth Ratio 0.09  0.11 

Pair Trading with Inogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inogen Stock

  0.61OTC Ocumetics Technology CorpPairCorr
  0.7AHC Austco HealthcarePairCorr

Moving against Inogen Stock

  0.7VMD Viemed HealthcarePairCorr
  0.57QIPT Quipt Home MedicalPairCorr
  0.494DX 4DMEDICALPairCorr
  0.46TRLS Trellus Health plcPairCorr
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Health Care Equipment & Supplies sector continue expanding? Could Inogen diversify its offerings? Factors like these will boost the valuation of Inogen. Market participants price Inogen higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.873
Earnings Share
(1.00)
Revenue Per Share
13.467
Quarterly Revenue Growth
0.04
Return On Assets
(0.06)
Investors evaluate Inogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Inogen's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inogen's market price signifies the transaction level at which participants voluntarily complete trades.